相关实验视频

Updated: Jun 14, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

通过计算分析探索自然化合物作为潜在的CDK4抑制剂用于神经退行性疾病的治疗干预

Neetu Rani¹, Pravir Kumar^2,3

¹Molecular Neuroscience and Functional Genomics Laboratory, Department of Biotechnology, Delhi Technological University (Formerly DCE), Shahbad Daulatpur, Bawana Road, Delhi, 110042, India.

Molecular biotechnology

|August 29, 2024

概括

两个天然化合物显示出作为神经退行性疾病的CDK4抑制剂的前景. 这些发现为阿尔茨海默氏症等疾病提供了潜在的新治疗途径.

科学领域:

药理学药理学是指药理学的学科.
计算化学计算化学
神经科学是一个神经科学.

背景情况:

循环素依赖性激酶4 (CDK4) 与神经退行性疾病有关.
CDK4是这些疾病的验证治疗标.
开发强大的CDK4抑制剂对于药物发现至关重要.

研究的目的:

为了确定新型天然产品的CDK4.4抑制剂.
在COCONUT数据库中选类似Palbociclib的化合物.
用计算方法评估潜在的CDK4抑制剂.

主要方法:

使用Tanimoto与Palbociclib.lib相似性的COCONUT数据库的虚拟选.
使用SWISSADME,Lipinski的5的规则和Brenk参数进行ADMET属性预测.
分子对接和动态模拟以评估与CDK4.4的结合亲和力和稳定性.

主要成果:

两种天然化合物 (CNP0396493和CNP0070947) 被确定为强大的CDK4抑制剂.
这些化合物表现出有利的药理动力学特性和血脑屏障的透性.
分子动力学模拟证实了CDK4-连接体复合物的稳定性.

结论:

天然产品 CNP0396493 和 CNP0070947 是神经保护的有希望的候选者.
这些化合物代表神经退行性疾病的潜在治疗剂.
需要进一步的研究来探索它们在临床前模型中的有效性和安全性.

关键词:

结合性亲缘关系是一种结合性亲缘关系.CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 CDK4 子数据库数据库中的子在MM/GBSA中使用.虚拟选是一个虚拟的选.

更多相关视频

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Positive Regulator Molecules

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.